AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Jan 16, 2013
30339_dirs_2013-01-16_567596d5-3fcf-4f38-84c0-431dde3eba1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-01-14
Reporting Person: LUZZI RICHARD D (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-14 | Common Stock | F | 614.0000 | $55.0500 | Disposed | 39641.1369 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 471.3637 | Indirect |
| Common Stock | 11133.8488 | Indirect |
Footnotes
F1: Change in the amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensation Plan for Designated Employees. These deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant.
F2: Change in amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensastion Plan for Designated Employees. 2,109 of these deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant and .77 of a share was distributed to the participant in cash.